Iron and levothyroxine are often prescribed to the same person. Iron deficiency is common, especially in women, and so is an underactive thyroid. The two don't mix well in the stomach, though: iron can bind to levothyroxine and leave less of the dose to absorb. Usually the answer is not to choose between them but to space them apart, and to let your prescriber know when your iron routine changes.
What the levothyroxine label says
The U.S. prescribing information for Synthroid, a widely used brand of levothyroxine, says to take it once a day on an empty stomach, half an hour to an hour before breakfast. It names ferrous sulfate, a common iron supplement, among the products that can bind levothyroxine, and tells patients not to take their tablet within four hours of iron or calcium supplements or antacids. The label's four hours is the standard to discuss with your pharmacist.
The study that first measured it
In a 1992 Canadian study, 14 people on a stable dose of thyroid hormone took a 300 mg ferrous sulfate tablet at the same time as their usual dose every day for 12 weeks. Their average TSH, the blood test used to adjust the dose, rose from 1.6 to 5.4 mU/L, and 9 of the 14 had more signs and symptoms of an underactive thyroid. In the lab, iron and thyroxine mixed together formed a poorly soluble complex, which points to binding in the gut as the cause (Campbell 1992). The study had no comparison group and tested only taking the two together, so it shows what happens without spacing, not what happens with it.
How often it shows up in practice
A Scottish study linked the prescription and blood-test records of nearly 11,000 people taking levothyroxine. Among those who started iron, TSH rose by 0.22 mU/L on average, a small change, but in 7.5% of them it rose by more than 5 mU/L (Irving 2015). The records didn't show how people timed their doses, so this is what happens in everyday practice, spacing or not. For most people the effect was small. For a minority it was large enough to matter.
Get The Signal by email. New research, grade changes and safety notes, about every two weeks. Subscribe free
Case reports: starting, stopping, and spacing
Case reports show the interaction from different angles. A patient in a 1997 report became underactive while taking ferrous sulfate, needed a higher levothyroxine dose, and then became overactive on that higher dose once the iron was stopped (Shakir 1997). That is why stopping iron matters as much as starting it. In a 2010 French report, a 95-year-old woman whose TSH rose after starting iron did not relapse once the two were taken separately (Fiaux 2010).
A 2026 report from England describes the exception. A 44-year-old woman took levothyroxine first thing in the morning and ferrous sulfate at night, more than four hours apart, yet her TSH stayed above 100 mU/L despite rising doses over nine months. A supervised test showed she absorbed levothyroxine normally. Her TSH returned to normal within six weeks of stopping oral iron and switching to iron given by infusion (Ei 2026). One case can't show how often spacing fails. It does show that if TSH stays high despite spacing, iron is worth raising with your clinician.
Do liquid forms avoid it?
Some evidence suggests so. In an Italian study, 19 people whose TSH was too high because of calcium or iron supplements were switched from levothyroxine tablets to a liquid form at the same dose, and most reached their TSH target at the first check, six to eight weeks later (Benvenga 2017). A 2023 review reached a similar view for liquid levothyroxine, with less data for soft-gel capsules (Maltese 2023). These are small studies without a placebo comparison, and which form you take is a decision for your prescriber.
Why you probably shouldn't just skip the iron
If your clinician prescribed iron, there is usually a reason, and the two conditions often travel together. In one trial of 51 people with iron-deficiency anemia and a mildly underactive thyroid, hemoglobin rose much more with iron plus levothyroxine than with iron alone (Cinemre 2009). The practical goal is to take both in a way that lets each work, not to drop one.
How to space them
- Take levothyroxine exactly as prescribed, usually first thing in the morning on an empty stomach, and take iron at least four hours later, as the label advises. Ask your pharmacist what timing works for your routine.
- If you take levothyroxine at bedtime, ask your pharmacist where iron fits rather than taking the two together.
- Check every product, not just the iron bottle. Many multivitamins and most prenatal vitamins contain iron, often alongside calcium, which is also on the label's four-hour list.
- Tell your prescriber when you start or stop iron, and ask whether a TSH recheck makes sense. Your dose was set around your current routine, and stopping iron can change what you need as much as starting it.
- If you are pregnant or planning a pregnancy, talk to your prescriber early. Thyroid dose needs often change in pregnancy, and so does iron use.
- If your TSH stays high even with spacing, mention your iron. In at least one reported case, the interaction persisted despite a four-hour gap.
The bottom line
Iron can bind levothyroxine and reduce how much you absorb. The original study took them together and saw TSH rise, population records show a small average effect with a minority of large ones, and case reports show it can work in both directions when iron is started or stopped. Keep them at least four hours apart, keep your routine consistent, and tell your prescriber whenever your iron changes.
References
- Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC. "Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism." Annals of Internal Medicine, 1992;117(12):1010–1013. PMID: 1443969.
- Irving SA, Vadiveloo T, Leese GP. "Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS)." Clinical Endocrinology, 2015;82(1):136–141. PMID: 25040647.
- Shakir KM, Chute JP, Aprill BS, Lazarus AA. "Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism." Southern Medical Journal, 1997;90(6):637–639. PMID: 9191742.
- Fiaux E, Kadri K, Levasseur C, Le Guillou C, Chassagne P. "[Hypothyroidism as the result of drug interaction between ferrous sulfate and levothyroxine]." La Revue de Médecine Interne (in French), 2010;31(10):e4–e5. PMID: 20554088.
- Ei ZP, Soe TT, Kyaw KH, Phyo HW, Lin NT. "Unmasking refractory hypothyroidism: persistent iron-levothyroxine interaction despite appropriate dose separation." Cureus, 2026;18(7):e112442. PMID: 42438581.
- Benvenga S, Di Bari F, Vita R. "Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine." Endocrine, 2017;56(1):138–145. PMID: 28155174.
- Maltese V, Gatta E, Facondo P, et al. "Simultaneous intake of liquid L-T4 formulation and iron salt: fact or fiction?" Acta Endocrinologica (Bucharest), 2023;19(1):54–58. PMID: 37601720.
- Cinemre H, Bilir C, Gokosmanoglu F, Bahcebasi T. "Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: a randomized, double-blind, controlled study." Journal of Clinical Endocrinology and Metabolism, 2009;94(1):151–156. PMID: 18984662.
- AbbVie. "Synthroid (levothyroxine sodium) tablets: prescribing information." DailyMed, label version of February 2024. dailymed.nlm.nih.gov
